课题基金 / 基金详情

Prox1 and oscillatory shear stress in aortic valve development and homeostasis

Prox1 and oscillatory shear stress in aortic valve development and homeostasis
主动脉瓣发育和稳态中的 Prox1 和振荡剪切应力
批准号:
10152357
负责人:
Anna Christina O'Donnell
金额:
$3.87万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-10 至 2022-12-09

项目摘要

项目成果

Anna Christina O'Donnell的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 先天性主动脉瓣畸形,包括二尖瓣,发生在大约2%的活产儿中, 获得性心脏瓣膜疾病,如钙化性主动脉瓣疾病,在美国约2.5%的人中发生。 人口。据推测,机械力对先天性和成人瓣膜疾病都有影响。最近 使用单细胞RNA鉴定表型和转录多样性的主动脉瓣(AOV)细胞群 成熟的小鼠主动脉瓣和二尖瓣的测序。首次发现三种截然不同的瓣膜内皮细胞 在AOV上的特定位置发现了(VEC)种群。每个地点都有独特的体验 机械力的组合对血管内皮细胞亚群的多样化可能是重要的。重要的是,一个 在AOV的纤维侧,血管内皮细胞经历OSS。这群人 优先表达转录因子Prox1,它是发育过程的主要调节因子,包括 多器官系统中的细胞命运和基因表达。在淋巴系统中,Prox1起着关键的调节作用 淋巴瓣膜(LymphV)发育和动态平衡对OSS的响应。因为Prox1出现在 小鼠胚胎13.5天的纤维膜侧半月瓣和Prox1一直存在到成年,它是 预测在AOV的发育和动态平衡过程中也存在类似的机制。中心假说 Prox1介导的是主动脉瓣形态发生和动态平衡 剪切力。目的1将确定纤维侧特异性Prox1是否促进血管形态发生和动态平衡 分析Prox1在胚胎和成年小鼠主动脉瓣中的表达 瓣膜发育和动态平衡。同时,Gata2和Cx37、Prox1‘S诱导物和Cx37的表达模式 下游靶点分别在LymphV血管内皮细胞,也将进行分析(1A)。此外,胚胎 成年内皮特异性Prox1功能丧失小鼠将被用来研究Prox1缺失的影响 Gata2和Cx37的表达,以及瓣膜的形态(1B)。在目标2中,改变切变的影响 对Prox1调节网络的压力及其与瓣膜动态平衡和疾病的关系将进行分析。 首先,Prox1、其淋巴诱导因子(Gata2)和下游靶基因(Cx37)的表达模式为 在猪Aov以及健康和患病的人Aov中进行了检查(2A)。接下来,生理学上的影响 在体外培养的猪AOV小叶中,Prox1上的相关异常剪应力模式将用 单锥板式生物反应器(2B)。我们的长期目标是确定AOV的机械敏感机制 发展、动态平衡和疾病与潜在的治疗应用。这项培训计划结合了 具有翻译含义的瓣膜生物学和生物工程的研究。我的职业目标是成为一名领导者 在理解机械环境如何影响心血管发育的过程中,体内平衡和 疾病。
英文摘要
Project Summary Congenital aortic valve malformations, including bicuspid aortic valve, occur in approximately 2% of live births, and acquired heart valve diseases, such as calcific aortic valve disease, occur in about 2.5% of the U.S. population. It is theorized that mechanical forces influence both congenital and adult valve disease. Recently phenotypic and transcriptionally diverse aortic valve (AoV) cell populations were identified using single-cell RNA sequencing of maturing murine aortic and mitral valves. For the first time, three distinct valve endothelial cell (VEC) populations were identified in specific locations on the AoV. Each location experiences a unique combination of mechanical forces which could be important in diversifying VEC subpopulations. Importantly, one of these populations is present on the fibrosa side of the AoV where the VECs experience OSS. This population preferentially expresses the transcription factor Prox1, a master regulator of developmental processes, including cell fate and gene expression, in multiple organ systems. In the lymphatic system, Prox1 acts as a key regulator of lymphatic valve (LymphV) development and homeostasis in response to OSS. As Prox1 is present on the fibrosa side of murine embryonic day (E)13.5 semilunar valves and Prox1 remains present into adulthood, it is predicted that a similar mechanism is active during AoV development and homeostasis. The central hypothesis of this proposal is that Prox1 mediates aortic valve morphogenesis and homeostasis in response to changes in shear stress. Aim 1 will determine if fibrosa side-specific Prox1 promotes morphogenesis and homeostasis in the aortic valve by analyzing the expression pattern of Prox1 in the AoV of embryonic and adult mice throughout valve development and homeostasis. In parallel, the expression pattern of Gata2 and Cx37, Prox1’s inducer and downstream target in LymphV endothelial cells respectively, will also be analyzed (1A). Additionally, embryonic and adult endothelial-specific Prox1 loss-of-function mice will be utilized to study the effect Prox1 deletion has on Gata2 and Cx37 expression, as well as on valve morphology (1B). In Aim 2, the effects of altered shear stress on a Prox1 regulatory network and its relationship to valve homeostasis and disease will be analyzed. First, the expression pattern of Prox1, its lymphatic inducer (Gata2) and downstream target (Cx37) will be examined in porcine AoVs and in healthy and diseased human AoVs (2A). Next, the impact of physiologically relevant aberrant shear stress patterns on Prox1 in porcine AoV leaflets cultured ex vivo will be studied using a single cone-and-plate bioreactor (2B). Our long-term goal is to identify mechanosensitive mechanisms of AoV development, homeostasis and disease with potential therapeutic applications. This training plan combines studies of valve biology and bioengineering with translational implications. My career goal is to become a leader in understanding how the mechanical environment influences cardiovascular development, homeostasis and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prox1 and oscillatory shear stress in aortic valve development and homeostasis
  • 批准号:
    9906371
  • 项目类别:
  • 资助金额:
    $3.82万
  • 财政年份:
    2019
  • 负责人:
    Anna Christina O'Donnell
  • 依托单位:
Prox1 and oscillatory shear stress in aortic valve development and homeostasis
  • 批准号:
    10307138
  • 项目类别:
  • 资助金额:
    $3.94万
  • 财政年份:
    2019
  • 负责人:
    Anna Christina O'Donnell
  • 依托单位:
海外基金